« Return to News | Technology Solutions

Agilent Technologies and National University of Singapore collaborate

Friday, April 1, 2011 12:00 PM

Agilent Technologies and the National University of Singapore (NUS) announced a collaboration in analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states.

Agilent’s provision of sophisticated test and measurement instruments will be housed in the NUS Center for Lipidomics within the university’s Life Sciences Institute. Headed by associate professor Markus Wenk, NUS department of biochemistry and department of biological sciences, this center will host researchers and scientists from clinical and commercial organizations in Singapore and the Asia Pacific region.

“Lipids play crucial roles in pathophysiology,” said professor John Wong, dean of the NUS Yong Loo Lin School of Medicine. “The close proximity of this new center to clinical research and patient care at the National University health system places us in a unique position for knowledge creation and translation in biomedicine.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.